Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Centogene US, LLC - The Rare Disease Company United States | 195 | 221 |
|
Centogene US, LLC - The Rare Disease Company United States | 316 | 314 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 669 | 688 |
|
Centogene US, LLC - The Rare Disease Company United States | 248 | 262 |
|
G6PC1 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 195 | 221 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
G6PC1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 165 |
|
Carrier Screening Ashkenazi Jewish Panel Ambry Genetics United States | 51 | 48 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 248 | 262 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
PreventionGenetics United States | 125 | 110 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Invitae Broad Carrier Screen without X-linked Disorders Invitae United States | 36 | 41 |
|
Invitae Comprehensive Carrier Screen without X-linked Disorders Invitae United States | 228 | 279 |
|
Invitae United States | 42 | 45 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.